Milpied, N <br/><br/>
Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 1996 
 - 1291-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1996.14.4.1291  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bone Marrow Transplantation--methods<br/>Case-Control Studies<br/>Europe<br/>Female<br/>Graft vs Host Disease<br/>Hodgkin Disease--therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Probability<br/>Proportional Hazards Models<br/>Survival Analysis<br/>Transplantation, Autologous<br/>Transplantation, Homologous<br/>Treatment Outcome